Ken Nelson is a commercial pioneer in the field of cardiac digital health and remote patient monitoring, and has led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries, building and leading the teams and cultures that launched all of the disruptive patch monitors for 3 of the top 4 market share players in cardiac digital health and remote patient monitoring, including #1 (BioTelemetry as Global VP of Sales), #2 (iRhythm as VP of Sales & Marketing), and #4 (Bardy Diagnostics as Chief Commercial Officer). 

Overall, he is a 25 year digital health, medical device, and remote patient monitoring executive and innovator with successful senior leadership experience ranging from a Fortune 500 company (Guidant / Boston Scientific) to a #1 market share leading medium sized company (Biotelemetry, acquisition by Philips for $2.8 Billion announced in December '20) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which was acquired by HillRom/ Baxter (Bardy Diagnostics) in August 2021 for $400+ Million after milestone payments. He also previously served as Head of Digital Health, Diagnostics, and Monitoring for Biotronik, a leading cardiac digital health and implantable medical device company.

Ken currently serves as partner and founder of Nelson Jennings Ventures (www.nelsonjenningsventures.com) where he collaborates closely with Medtech Innovator (www.medtechinnovator.org ), the largest MedTech and Digital Health startup accelerator globally, as both a judge and mentor.  He is also a Venture Partner and LP Investor for Star51 Capital.  In addition, he serves as an active Board of Directors member for HeartBeam (NASDAQ:  BEAT), Echo IQ (Sydney, Australia – Ticker ASX: EIQ), Acarix (Stockholm, Sweden NASDAQ:  ACARIX), Epitel (Salt Lake City, UT), Happitech (Amsterdam, Netherlands), and on the Strategic Advisory Boards of a handful of other disruptive cardiac Digital Health and MedTech startups.  He is also on the advisory boards and/or planning committees HeartX (MedAxiom/ ACC), HRX (Digital Health Summit of Heart Rhythm Society), the Innovation Advisory Board of Heart Rhythm Society (HRS) and on both the AHA Health Tech Innovation Business Advisory Board and the Heart & Brain Startup Accelerator Selection Committee of the American Heart Association and MedTech Innovator.

Ken earned a B.A. in Economics from Vanderbilt University, is a graduate of Phillips Exeter Academy,  and resides in Dallas, TX with his wife and 3 children.